Check out our most popular compounded medications! Get Started
The Mometasone Furoate 0.6 mg/ml/Tobramycin 125 mg/ml Nasal Gel is a specialized medication compounded for the treatment of chronic rhinosinusitis, nasal polyps, and bacterial infections of the nasal passages. This gel-like formulation is designed for ease of application within the nasal cavity, where it exerts its dual-action therapeutic effects. Mometasone Furoate, a potent corticosteroid, reduces inflammation and swelling, thereby alleviating symptoms associated with nasal polyps and chronic rhinosinusitis. Concurrently, Tobramycin, an aminoglycoside antibiotic, targets and eradicates susceptible bacterial pathogens, addressing the infectious component of nasal conditions. The gel base provides a soothing and moisturizing effect, enhancing patient comfort and supporting the maintenance of healthy nasal tissue. Dispensed in a convenient tube, this nasal gel offers targeted relief and is an integral part of a comprehensive treatment regimen for the aforementioned nasal disease states.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Mometasone Furoate 0.6 mg/ml/Tobramycin 125 mg/ml Nasal Gel is a compounded medication designed to address a variety of nasal conditions. Mometasone Furoate is a potent corticosteroid that exerts anti-inflammatory, antipruritic, and vasoconstrictive properties. When applied topically within the nasal cavity, it effectively reduces inflammation and swelling, which can be beneficial for patients suffering from allergic rhinitis, nasal polyps, or other inflammatory nasal conditions. The inclusion of Tobramycin, an aminoglycoside antibiotic, provides antibacterial coverage, making this formulation particularly useful in treating nasal infections where a bacterial component is suspected or confirmed.
The gel base offers a soothing and moisturizing effect, which can alleviate symptoms of nasal dryness and irritation. This can be especially helpful in environments that contribute to dry nasal passages, such as air-conditioned or heated rooms. The gel formulation is designed to adhere to the nasal mucosa, providing a prolonged contact time and ensuring that the active ingredients are delivered directly to the affected area. This targeted approach helps to maximize therapeutic effects while minimizing systemic absorption and potential side effects.
For prescribers, it is important to note that this formulation should be used with caution in patients with a known hypersensitivity to any of the ingredients, and it is not intended for ophthalmic use. The use of corticosteroids, such as Mometasone Furoate, may be associated with local side effects such as nasal irritation or epistaxis, and systemic effects if absorbed in significant amounts. Tobramycin, while generally safe when used topically, should be prescribed with caution in patients with a history of aminoglycoside hypersensitivity or renal impairment. As with all compounded medications, this formulation should be prescribed only when commercial products are not suitable for the patient's needs.
Patients should be instructed on the proper administration technique to ensure the effectiveness of the medication and to minimize the risk of side effects. The nasal gel should be applied as directed by the prescriber, usually in a small amount to the inside of each nostril. Patients should be advised to avoid contact with the eyes and to report any unusual symptoms or signs of infection during use. As with all medications, adherence to the prescribed regimen is crucial for optimal therapeutic outcomes.
If you have any questions or require further information about the Mometasone Furoate 0.6 mg/ml/Tobramycin 125 mg/ml Nasal Gel, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support to both patients and healthcare providers.
The combination of mometasone furoate and tobramycin in a nasal gel formulation is designed to provide anti-inflammatory and antibiotic effects, respectively, for the treatment of various nasal conditions. Mometasone furoate is a corticosteroid that reduces inflammation and swelling in the nasal passages, which can be beneficial for conditions such as allergic rhinitis or sinusitis. Tobramycin is an aminoglycoside antibiotic that can help to treat bacterial infections within the nasal cavity.
When considering the use of this combination nasal gel, it is important to be aware of potential drug interactions. Mometasone furoate, being a corticosteroid, may interact with drugs that induce or inhibit cytochrome P450 (CYP) enzyme activity, particularly CYP3A4. Inhibitors of CYP3A4, such as ketoconazole, itraconazole, and certain HIV protease inhibitors, may increase the plasma concentrations of mometasone, potentially leading to an increased risk of systemic corticosteroid effects such as adrenal suppression or Cushing's syndrome. Conversely, inducers of CYP3A4, such as phenytoin, phenobarbital, and rifampin, may decrease the efficacy of mometasone.
Tobramycin, on the other hand, may interact with other nephrotoxic or ototoxic drugs, potentially increasing the risk of kidney damage or hearing loss. These include drugs such as loop diuretics (e.g., furosemide), nonsteroidal anti-inflammatory drugs (NSAIDs), and other aminoglycosides. Caution is advised when co-administering these medications. Additionally, the use of tobramycin with neuromuscular blocking agents or ethacrynic acid may enhance the potential for neuromuscular blockade or ototoxicity, respectively.
It is also important to consider the potential for systemic absorption of both mometasone and tobramycin when applied topically in the nasal cavity, although this is generally low. Patients with pre-existing conditions such as hepatic impairment, renal impairment, or those who are immunocompromised should be monitored closely due to the increased risk of systemic side effects and interactions.
Patients should be advised to inform their healthcare provider of all medications they are taking, including prescription drugs, over-the-counter medications, and herbal supplements, to assess for potential interactions. Additionally, patients should be monitored for any signs of adverse effects or changes in the efficacy of their other medications.
For any questions or concerns regarding the use of this nasal gel formulation or potential drug interactions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is available to provide guidance and support to both patients and prescribers to ensure safe and appropriate use of this medication.
The Mometasone Furoate 0.6 mg/ml/Tobramycin 125 mg/ml Nasal Gel is a specialized medication designed for the treatment of various nasal conditions. This gel-like formulation is dispensed in a tube and is intended for topical application within the nasal cavity. The medication combines the anti-inflammatory properties of Mometasone Furoate with the antibiotic action of Tobramycin, offering a dual approach to managing symptoms and treating underlying causes of nasal discomfort.
Mometasone Furoate is a potent corticosteroid that works by reducing inflammation in the nasal passages. When applied topically, it helps to alleviate symptoms such as swelling, itching, and congestion. This can be particularly beneficial for patients suffering from allergic rhinitis or other inflammatory nasal conditions. By decreasing inflammation, Mometasone Furoate can improve airflow and reduce discomfort, contributing to an overall enhancement of nasal comfort and function.
In the context of nasal application, Tobramycin targets bacterial infections within the nasal cavity that can contribute to symptoms such as discharge, crusting, and odor. By eradicating bacterial pathogens, Tobramycin helps to restore a healthy nasal environment, which is essential for the proper functioning of the nasal mucosa and cilia.
The gel formulation itself is designed to provide a soothing and moisturizing effect on the nasal passages. Its consistency allows for the medication to adhere to the mucosal surfaces, ensuring prolonged contact and sustained release of the active ingredients. This can be particularly advantageous for patients experiencing nasal dryness or irritation, as the gel helps to maintain a hydrated environment, promoting healing and preventing further irritation.
Together, the combination of Mometasone Furoate and Tobramycin in a gel base provides a comprehensive treatment option for patients with nasal conditions that require both anti-inflammatory and antibiotic care. It is important for patients and prescribers to note that this medication should be used as directed, and it is essential to follow the prescribed dosing regimen to achieve optimal results. As with any medication, potential side effects and contraindications should be reviewed prior to use.
If you have any questions or require further information about the Mometasone Furoate 0.6 mg/ml/Tobramycin 125 mg/ml Nasal Gel, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure the safe and appropriate use of this formulation.
This compounded nasal gel is designed to treat various nasal conditions by providing anti-inflammatory and antibiotic effects to reduce nasal dryness, congestion, or irritation. It helps soothe and moisturize the nasal passages, promoting comfort and supporting healthy nasal function.
To apply the nasal gel, ensure your hands are clean. Squeeze a small amount of gel onto a fingertip or cotton swab and gently apply it inside each nostril, as directed by a healthcare provider. Be careful not to insert the tube or your finger too far into the nose.
The frequency of use will depend on your healthcare provider's instructions. Typically, it is used one or two times a day, but your doctor may recommend a different schedule based on your specific condition.
Possible side effects may include local irritation, dryness, sneezing, nosebleeds, or headache. If you experience any severe reactions or signs of an allergic response, contact your healthcare provider immediately.
Before using this medication, inform your healthcare provider if you are pregnant or breastfeeding. They will determine if the benefits outweigh the risks and provide a recommendation based on your individual circumstances.
Usage in children should only be under the supervision and direction of a pediatrician or healthcare provider. The suitability and dosage will be tailored to the child's specific condition and needs.
Keep the nasal gel at room temperature, away from light and moisture. Avoid freezing it, and keep the tube tightly closed when not in use. Ensure it's stored out of reach of children and pets.
Long-term use should be monitored by a healthcare provider since prolonged use of corticosteroids and antibiotics may have additional risks. Follow your healthcare provider's instructions regarding the duration of treatment.
If you miss a dose, apply it as soon as you remember. However, if it's almost time for your next dose, skip the missed one and resume your regular dosing schedule. Avoid doubling up on doses to compensate for the missed one.
Consult with your healthcare provider before combining treatments, as other nasal products might interact with the nasal gel. They can advise you on the safe use of additional medications or products.
If you suspect an overdose or if the gel has been ingested, seek emergency medical attention immediately. Symptoms of an overdose may be similar to the side effects but could be more severe.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply
